An Alaska woman had the scare of a lifetime when she was attacked by a bear while using an outhouse in the backcountry.
N.C. 3AA state champion Weddington beat N.C. 3A state champion Charlotte Catholic in a defensive battle in front of 1,300 fans Friday
March 5 (Reuters) - "just setting up my twttr" - the first ever tweet on the platform is up for sale after Twitter boss Jack Dorsey listed his famous post as a unique digital signature on a website for selling tweets as non-fungible tokens (NFTs). The post, sent from Dorsey's account in March of 2006, received offers on Friday that went as high as $88,888.88 within minutes of the Twitter co-founder tweeting a link to the listing on 'Valuables by Cent' - a tweets marketplace. Old offers for the tweet suggest that it was put for sale in December, but the listing gained more attention after Dorsey's tweet on Friday.
When Carter helps Kat get elected to the local business council, a rift forms in their friendship when she doesn't vote in his favor to keep the bar open later. Meanwhile, Sheila asks Max to help her move some of her furniture to make room for her boyfriend, and Randi asks Phil for help with her photography project.
Sri Lanka’s spinners bowled the tourists to a 43-run win over the West Indies in the second Twenty20 cricket international on Friday, leveling the three-match series at 1-1. Defending a moderate total of 160-6, Wanindudu Hasaranga, Akila Dananjaya and Danushka Gunathilaka took eight wickets, bowling out the West Indies for 117 in 18.4 overs. Sri Lanka stacked its lineup with four spinners for the must-win match at Coolidge and the tactic paid off on a slow pitch which made big hitting difficult.
Helping the market to end the week strongly was a better-than-expected employment report released on Friday morning. But while more people were on payrolls, they were working shorter hours.
Sen. Bernie Sanders tried to force a vote on the proposal, which died on procedural grounds.
Miami-Dade Mayor Daniella Levine Cava won’t lift the county’s midnight curfew in March, leaving the COVID-19 business restriction in place through the peak of Spring Break unless lawmakers or courts intervene.
As U.S. technology shares stumble, investors are debating whether the decline is an opportunity to scoop up bargains or a sign of more pain to come for stocks that have led markets higher for years. The Nasdaq Composite, an index heavily populated by tech and growth names, has slumped 8.3% since its Feb 12 closing record, over three times the decline for the S&P 500. Drops in popular growth stocks have been even steeper, with Tesla shares off 27% and Peloton down 32%.
Senate leaders and moderate Democratic Sen. Joe Manchin struck a deal late Friday over emergency jobless benefits, breaking a nine-hour logjam that had stalled the party’s showpiece $1.9 trillion COVID-19 relief bill.
This might be the cutest way to fight undereye bags
NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased Tricida, Inc. (NASDAQ: TCDA) securities between September 4, 2019 and October 28, 2020 (the “Class Period”). Investors have until March 8, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. Tricida is a pharmaceutical company that focuses on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally administered polymer designed as a potential treatment for metabolic acidosis in patients with CKD. Tricida has completed a Phase 3, double-blind, placebo-controlled trial of veverimer in patients with CKD and metabolic acidosis. On September 4, 2019, Tricida announced that it had submitted a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) under the Accelerated Approval Program for approval of veverimer for the treatment of metabolic acidosis in patients with CKD. On July 15, 2020, Tricida issued a press release announcing that, on July 14, 2020, the Company received a notification from the FDA, stating that as part of the FDA’s ongoing review of the Company’s NDA for veverimer, “the FDA has identified deficiencies that preclude discussion of labeling and post marketing requirements/commitments at this time.” Tricida stated that “[t]he notification does not specify the deficiencies identified by the FDA.” On this news, Tricida’s stock price fell $10.56 per share, or 40.31%, to close at $15.64 per share on July 16, 2020. Then, on October 29, 2020, Tricida announced an update on its End-of-Review Type A meeting with the FDA regarding the veverimer NDA, advising investors that the Company “now believes the FDA will also require evidence of veverimer’s effect on CKD progression from a near-term interim analysis of the VALOR-CKD trial for approval under the Accelerated Approval Program and that the FDA is unlikely to rely solely on serum bicarbonate data for determination of efficacy.” Concurrently, Tricida disclosed that it “is significantly reducing its headcount from 152 to 59 people and will discuss its commitments with vendors and contract service providers to potentially provide additional financial flexibility.” On this news, Tricida's stock price fell $3.90 per share, or 47.16%, to close at $4.37 per share on October 29, 2020. The complaint, filed on January 6, 2021, alleges that throughout the Class Period defendants made materially false and misleading statements, and failed to disclose material adverse facts about the Company’s business, operational, and compliance policies. Specifically, defendants made false and/or misleading statements and failed to disclose to investors that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times. If you purchased Tricida securities during the Class Period and suffered a loss, are a long-term stockholder have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Melissa Fortunato, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against 3D Systems Corporation (NYSE: DDD) on behalf of 3D Systems stockholders. Our investigation concerns whether 3D Systems has violated the federal securities laws and/or engaged in other unlawful business practices.
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Baker Hughes Company (NYSE: BKR) on behalf of Baker Hughes stockholders. Our investigation concerns whether Baker Hughes has violated the federal securities laws and/or engaged in other unlawful business practices.
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Leidos Holdings, Inc. (NYSE: LDOS) securities between May 4, 2020 and February 23, 2021, inclusive (the "Class Period"). Investors have until May 3, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Atlantic Power Corp. ("AT" or the "Company") (AT) relating to its proposed merger with Tidal Power Goldings Limited. Under the terms of the agreement, AT shareholders are expected to receive US$3.03 and C$22.00 in cash per share.
The upcoming event highlights a continuing GOP divide.
It was not exactly the Senior Night they envisioned when they arrived on the University of Miami campus – an empty, cavernous Watsco Center with just a smattering of family members and cardboard cutout fans in attendance.
Saturday will be brisk and cold with more clouds and temperatures hovering in the mid 30s.
Boston Bruins defenseman Brandon Carlo immediately grabbed his head after hit from Washington Capitals' Tom Wilson and needed help leaving ice.
Yahoo Home